Evidence map›Paper›PMID 40502793›Full record

ArticleResearch square2025

Unique lipid cargoes in APOE4 human brain-derived extracellular vesicles recruit cell adhesion molecules and promote tauopathy in Alzheimer's disease.

Tsuneya Ikezu, Zhengrong Zhang, Kaiwen Yu, Hanmei Bao, Tadafumi Ikezu, Arun Reddy Ravula, Bridgette Melvin, Clara Scholes, Yang You, Justice Ellison and 7 more

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Tsuneya IkezuMayo Clinic Florida.ORCID 0000-0002-3979-8596
Zhengrong ZhangMayo Clinic Florida.
Kaiwen YuSt. Jude Children's Research Hospital.ORCID 0000-0002-6050-8477
Hanmei BaoUniversity of Texas Health Science Center at San Antonio.
Tadafumi IkezuMayo Clinic.
Arun Reddy RavulaMayo Clinic Florida.
Bridgette MelvinMayo Clinic Florida.
Clara ScholesUniversit of Manchester.
Yang YouMayo Clinic Floria.ORCID 0000-0003-0574-7827
Justice EllisonMayo Clinic Florida.
Takahisa KanekiyoMayo Clinic Jacksonville.ORCID 0000-0001-6751-9374
Zbigniew WszolekMayo Clinic College of Medicine.ORCID 0000-0001-5487-1053
Michael DeTureDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida.
Dennis DicksonMayo Clinic Florida.
Xianlin HanUT Health San Antonio.ORCID 0000-0002-8615-2413
Junmin PengSt Jude Children's Research Hospital.ORCID 0000-0003-0472-7648
Seiko IkezuMayo Clinic Florida.

Funding

Technology and Remote Assessment CoreU19AG063911 · NIA · MAYO CLINIC ROCHESTER · PI KEJAL KANTARCI · 2019 to 2026
$120.9M
Exosome-mediated propagation of pathogenic tau proteinRF1AG054199 · NIA · MAYO CLINIC JACKSONVILLE · PI IKEZU, TSUNEYA · 2016 to 2021
$5.0M
Targeting the miR-155 and APOE-TREM2 pathways to restore dysfunctional microglia in Alzheimer’s diseaseR01AG054672 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI BUTOVSKY, OLEG, IKEZU, TSUNEYA · 2017 to 2021
$4.1M
Molecular characterization of extracellular vesicles for the spread of misfolded tau proteinR01AG067763 · NIA · MAYO CLINIC JACKSONVILLE · PI IKEZU, TSUNEYA · 2021 to 2025
$3.1M
Assessment of a novel tau propagation pathway from layer II medial entorhinal cortical neurons to CA1 pyramidal neurons as an early Braak stage mouse modelR01AG072719 · NIA · MAYO CLINIC JACKSONVILLE · PI IKEZU, TSUNEYA · 2021 to 2025
$2.7M
Therapeutic evaluation of targeting Tau Tubulin kinase-1 in Alzheimer’s diseaseR01AG079859 · NIA · MAYO CLINIC JACKSONVILLE · PI Seiko Ikezu · 2023 to 2026
$2.2M
Targeting emerging P2RX7 signaling pathways in animal models of Alzheimer's diseaseR01AG066429 · NIA · MAYO CLINIC JACKSONVILLE · PI IKEZU, TSUNEYA · 2020 to 2024
$2.0M
NIA NIH HHS R01 AG054672NIA NIH HHS R01 AG066429NIA NIH HHS R01 AG067763NIA NIH HHS R01 AG072719NIA NIH HHS R01 AG079859NIA NIH HHS RF1 AG054199NIA NIH HHS U19 AG063911
6 · The paper itself

Abstract

Brain-derived extracellular vesicles (BDEVs) carry tau filaments and promote tau transmission in Alzheimer's disease (AD). However, how APOE ε4 allele, a key genetic risk factor for AD, may change BDEV molecular structures thereby facilitate disease progression is poorly understood. Here we report comprehensive analyses of BDEVs isolated from human E3/3 and E4/4 AD brains with a biological multi-omics approach. E4/4 BDEVs significantly enhanced tau propagation in aged human

Indexed as

Alzheimer’ Diseaseapolipoprotein Eextracellular vesiclesfree fatty acidshumanized animal modelsinduced pluripotent stem cellslipidomicsneural cell adhesion molecule 1proteomics

Identifiers

PMID40502793
PMCPMC12154133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.